STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIP
  4. [Form 4] Arteris, Inc. Insider Trading Activity

Trust linked to Arteris (AIP) director sells 70,000 shares in 10b5-1 trades

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. director Saiyed Atiq Raza reported significant insider sales of Arteris (AIP) common stock. On 2026-07-01, a revocable trust for which he serves as trustee sold an aggregate of 70,000 shares in multiple open-market transactions at weighted-average prices including $47.1004, $44.9884, $43.9796 and $46.1987 per share. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025. After the sales, the trust held 119,041 shares of common stock, and Raza also held 4,703 shares directly.

Positive

  • None.

Negative

  • None.
Insider RAZA SAIYED ATIQ
Role null
Sold 70,000 shs ($3.18M)
Type Security Shares Price Value
Sale Common Stock 20,959 $46.1987 $968K
Sale Common Stock 26,138 $43.9796 $1.15M
Sale Common Stock 9,270 $44.9884 $417K
Sale Common Stock 13,633 $47.1004 $642K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 119,041 shares (Indirect, By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012); Common Stock — 4,703 shares (Direct, null)
Footnotes (1)
  1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.68 to $46.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.68 to $44.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.64 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.68 to $47.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 70,000 shares Total Arteris common shares sold by trust on July 1, 2026
Sale price tranche $47.1004 per share Weighted-average sale price for one transaction block
Sale price tranche $44.9884 per share Weighted-average sale price for another transaction block
Sale price tranche $43.9796 per share Weighted-average sale price for another transaction block
Sale price tranche $46.1987 per share Weighted-average sale price for another transaction block
Indirect holdings after sale 119,041 shares Arteris common shares held by revocable trust post-transaction
Direct holdings after sale 4,703 shares Arteris common shares held directly by reporting person
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Revocable Trust financial
"The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RAZA SAIYED ATIQ
(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300
(Street)
CAMPBELL CALIFORNIA 95008
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026S(1)20,959D$46.1987(2)119,041IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock07/01/2026S(1)26,138D$43.9796(4)92,903IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012
Common Stock07/01/2026S(1)9,270D$44.9884(5)83,633IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012
Common Stock07/01/2026S(1)13,633D$47.1004(6)70,000IBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012
Common Stock4,703D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.68 to $46.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.68 to $44.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.64 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.68 to $47.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Arteris (AIP) disclose for Saiyed Atiq Raza?

Arteris disclosed that a revocable trust associated with director Saiyed Atiq Raza sold 70,000 shares of common stock in open-market transactions. The sales occurred on July 1, 2026, at various weighted-average prices in the mid-$40 range per share.

How many Arteris (AIP) shares did the trust sell and at what prices?

The trust sold a total of 70,000 Arteris common shares. The filing lists weighted-average sale prices including $47.1004, $44.9884, $43.9796 and $46.1987 per share, reflecting multiple transactions executed across a price range in the mid-$40s.

Were the Arteris (AIP) insider sales under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made under a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025. Such pre-arranged plans allow insiders to schedule trades in advance, reducing discretion over timing.

How many Arteris (AIP) shares does Saiyed Atiq Raza hold after these transactions?

After the reported sales, the revocable trust held 119,041 Arteris common shares, and Raza also held 4,703 shares directly. These post-transaction balances come from the ownership columns showing shares beneficially owned following the transactions.

Who legally holds the Arteris (AIP) shares involved in the reported sales?

The sold shares are held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, dated November 26, 2012. The filing explains that the reporting person serves as trustee of this revocable trust, which is the entity executing the sales.